• Skip to main content
  • Skip to primary sidebar
  • Home
  • News
  • Education
  • Events
  • Interviews
    • Career spotlight
  • Opinion
    • Professional Dilemmas
    • Patient perspective
  • PIPcast
  • Jobs
  • Business Directory

Pharmacy in Practice

EDX/20/1154
Date of prep: December 2020

Prescribing information and
adverse events reporting

For healthcare professionals only

MHRA crack down on bogus COVID-19 miracle cures

4th April 2020 by PIP editor Leave a Comment

 

An increasing number of bogus medical products being sold through unauthorised websites claiming to treat or prevent COVID-19 are being investigated by the Medicines and Healthcare products Regulatory Agency (MHRA).

 

The MHRA has said that these include self-testing kits, ‘miracle cures’, ‘antiviral misting sprays’, and unlicensed medicines.

 

The MHRA has disabled 9 domain names and social media accounts selling fake or unauthorised COVID-19 products.

 

The National Fraud Intelligence Bureau is also seeing reports from victims who have lost money when they have tried to purchase PPE or self-testing kits online, from fraudulent websites, that simply do not exist.

 

At this time, there are currently no medicines licensed specifically for the treatment or prevention of COVID-19 and there are no CE marked self-testing kits approved for home use.

 

Lynda Scammell, MHRA Enforcement Official said:

 

“Don’t be fooled by online offers for medical products to help prevent or treat COVID-19

 

“There is no medicine licensed specifically to treat or prevent COVID-19, therefore any claiming to do so are not authorised and have not undergone regulatory approvals required for sale on the UK market. We cannot guarantee the safety or quality of the product and this poses a risk to your health.

 

“The risk of buying medicines and medical devices from unregulated websites are that you just don’t know what you will receive and could be putting your health at risk.

 

“We are working alongside other law enforcement agencies to combat this type of criminal activity.”

 

 

This circular is being shared under the Open Government Copyright licence.

 

 

Share this:

  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to email this to a friend (Opens in new window)

Related

Next article  FIP and WHO join forces to fight fake medicines problem

Filed Under: COVID-19, News Tagged With: Fake meds, PIP news

Register for our upcoming webinar and live Q&A

About PIP editor

Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.

Reader Interactions

Begin the discussion right here Cancel reply

Primary Sidebar

Categories

Follow Us

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Twitter

PIP business directory

Letters to the editor

Letters to the editor

Pharmacists should not have to bend the rules

I have seen people slide into addiction after taking OTC opiates

The ‘ART’ of Scottish community pharmacy is all about data

Community pharmacists can identify high-risk asthmatic patients

More letters to the editor here...

Blogs

💊 PIP live pharmacy blog

Winter stresses must not ‘destabilise’ general practice

What is it like to depend on medicine to treat endometriosis?

Opinion

Why is pharmacy not integral to government mass vaccination plans?

Pharmacy Covid-19 vaccination involvement is a ‘no-brainer’

The great patient medication returns debacle

CPD Challenges

💊 CPD Challenge: How well do you understand pulmonary embolisms?

💊 CPD Challenge: Prescribing and dispensing clozapine

💊 CPD Challenge: Oral anticoagulants – Dabigatran

More CPD challenges here...

© 2021 · About Pharmacy In Practice · Site mantained by Mike

This site is for healthcare professionals, please confirm you are a healthcare professional to continue.

YES

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
Pharmacy In Practice uses cookies, by continuing to use this site we will assume you are ok with that Find out more.